eep < effect < effective

Facettes :

List of bibliographic references indexed by effect

Number of relevant bibliographic references: 225.
[20-40] [0 - 20][0 - 50][40-60]

Ident.	Authors (with country if any)	Title
000A54 (2014)	Sarah Christine Lidstone [Canada]	Great expectations: the placebo effect in Parkinson's disease.
000A76 (2014)	Atsuko Nagano-Saito [Canada] ; Claudine Habak ; Beatriz Mejía-Constaín ; Clotilde Degroot ; Laura Monetta ; Thomas Jubault ; Christophe Bedetti ; Anne-Louise Lafontaine ; Sylvain Chouinard ; Valérie Soland ; Alain Ptito ; Antonio P. Strafella ; Oury Monchi	Effect of mild cognitive impairment on the patterns of neural activity in early Parkinson's disease.
000A77 (2014)	Stephanie Chu [Canada] ; Wei Xiong ; Fiona E. Parkinson	Effect of ecto-5'-nucleotidase (eN) in astrocytes on adenosine and inosine formation.
000A78 (2014)	Lisa-Ann Fraser [Canada] ; Jonathan D. Adachi [Canada] ; William D. Leslie [Canada] ; David Goltzman [Canada] ; Robert Josse [Canada] ; Jerilynn Prior [Canada] ; Stephanie Kaiser [Canada] ; Nancy Kreiger [Canada] ; Christopher S. Kovacs [Canada] ; Tassos P. Anastassiades [Canada] ; Alexandra Papaioannou [Canada]	Effect of Anticholinergic Medications on Falls, Fracture Risk, and Bone Mineral Density Over a 10-Year Period
000A91 (2014)	Katerina Markopoulou [États-Unis] ; Joanna M. Biernacka [États-Unis] ; Sebastian M. Armasu [États-Unis] ; Kari J. Anderson [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Bruce A. Chase [États-Unis] ; Sun Ju Chung [Corée du Sud] ; Julie M. Cunningham [États-Unis] ; Matthew Farrer [Canada] ; Roberta Frigerio [États-Unis] ; Demetrius M. Maraganore [États-Unis]	Does α-Synuclein Have A Dual and Opposing Effect in Preclinical versus Clinical Parkinson’s Disease?
000B38 (2014)	Kristina Martinu [Canada] ; Atsuko Nagano-Saito [Canada] ; Stuart Fogel [Canada] ; Oury Monchi [Canada]	Asymmetrical Effect of Levodopa on the Neural Activity of Motor Regions in PD
000B55 (2014)	Véronique Daneault [Canada] ; Marc Hébert ; Geneviève Albouy [Canada] ; Julien Doyon [Canada] ; Marie Dumont [Canada] ; Julie Carrier [Canada] ; Gilles Vandewalle [Canada]	Aging Reduces the Stimulating Effect of Blue Light on Cognitive Brain Functions
000B83 (2014)	Stéphanie Bissonnette [Canada] ; Sophie Muratot [Canada] ; Nathalie Vernoux [Canada] ; François Bezeau [Canada] ; Frédéric Calon [Canada] ; Sébastien S. Hebert [Canada] ; Pershia Samadi [Canada]	The effect of striatal pre-enkephalin overexpression in the basal ganglia of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
000C12 (2014)	Tiago A. Mestre [Canada] ; Prakesh Shah [Canada] ; Connie Marras [Canada] ; George Tomlinson [Canada] ; Anthony E. Lang [Canada]	Another face of placebo: The lessebo effect in Parkinson disease: Meta-analyses
000C14 (2014)	Arthur G. Fitzmaurice [États-Unis] ; Shannon L. Rhodes [États-Unis] ; Myles Cockburn [États-Unis] ; Beate Ritz [États-Unis] ; Jeff M. Bronstein [États-Unis, Canada]	Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease
000C41 (2013)	Michael G. Heckman [États-Unis] ; Alexis Elbaz [France] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Daniel J. Serie [États-Unis] ; Jan O. Aasly [Norvège] ; Grazia Annesi [Italie] ; Georg Auburger [Allemagne] ; Justin A. Bacon [États-Unis] ; Magdalena Boczarska-Jedynak [Pologne] ; Maria Bozi [Grèce] ; Laura Brighina [Italie] ; Marie-Christine Chartier-Harlin [France] ; Efthimios Dardiotis [Grèce] ; Alain Destée [France] ; Carlo Ferrarese [Italie] ; Alessandro Ferraris [Italie] ; Brian Fiske [États-Unis] ; Suzana Gispert [Allemagne] ; Georgios M. Hadjigeorgiou [Grèce] ; Nobutaka Hattori [Japon] ; John P. A. Ioannidis [Grèce, États-Unis] ; Barbara Jasinska-Myga [Pologne] ; Beom S. Jeon [Corée du Sud] ; Yun Joong Kim [Corée du Sud] ; Christine Klein [Allemagne] ; Rejko Kruger [Allemagne] ; Elli Kyratzi [Grèce] ; Chin-Hsien Lin [Taïwan] ; Katja Lohmann [Allemagne] ; Marie-Anne Loriot [France] ; Timothy Lynch [Irlande (pays)] ; George D. Mellick [Australie] ; Eugénie Mutez [France] ; Grzegorz Opala [Pologne] ; Sung Sup Park [Corée du Sud] ; Simona Petrucci [Italie] ; Aldo Quattrone [Italie] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Young Ho Sohn [Corée du Sud] ; Leonidas Stefanis [Grèce] ; Vera Tadic [Allemagne] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Enza Maria Valente [Italie] ; Demetrios K. Vassilatis [Grèce] ; Carles Vilari O-Güell [Canada] ; Linda R. White [Norvège] ; Karin Wirdefeldt [Suède] ; Zbigniew K. Wszolek [États-Unis] ; Ruey-Meei Wu [Taïwan] ; Georgia Xiromerisiou [Grèce] ; Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [Canada] ; Owen A. Ross [États-Unis]	The protective effect of LRRK2 p.R1398H on risk of Parkinson’s disease is independent of MAPT and SNCA variants
000C81 (2013)	Justine Renaud ; Julie Bournival ; Ximena Zottig ; Maria-Grazia Martinoli	Resveratrol Protects DAergic PC12 Cells from High Glucose-Induced Oxidative Stress and Apoptosis: Effect on p53 and GRP75 Localization
000D37 (2013)	Danielle Murray [Canada] ; A Jon Stoessl	Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions.
000D41 (2013)	Jing Shen [République populaire de Chine] ; Mohammad A. Kassir [États-Unis] ; Jianlin Wu [République populaire de Chine] ; Qing Zhang [République populaire de Chine] ; Shiyu Zhou [République populaire de Chine] ; Stephanie Y. Xuan [Canada] ; Qinghang Li [États-Unis] ; Yongquan Ye [États-Unis] ; Jiani Hu [États-Unis]	MR Volumetric Study of Piriform-Cortical Amygdala and Orbitofrontal Cortices: The Aging Effect
000D52 (2013)	Joan Parkinson [Canada] ; Heather Sandusky ; Francois Tremblay	Interocular effect during visual acuity measurement with and without amblyopia.
000E49 (2013)	Ronald B. Postuma [Canada] ; Jean-Francois Gagnon [Canada] ; Maria Tuineaig [Canada] ; Josie-Anne Bertrand [Canada] ; Veronique Latreille [Canada] ; Catherine Desjardins [Canada] ; Jacques Y. Montplaisir [Canada]	Antidepressants and REM Sleep Behavior Disorder: Isolated Side Effect or Neurodegenerative Signal?
000F63 (2013)	Alex A. Macdonald [Canada] ; Oury Monchi [Canada] ; Ken N. Seergobin [Canada] ; Hooman Ganjavi [Canada] ; Ruzbeh Tamjeedi [Canada] ; Penny A. Macdonald [Canada]	Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function
000F87 (2013)	Tobias Krettenauer [Canada] ; Fanli Jia [Canada]	Investigating the actor effect in moral emotion expectancies across cultures: A comparison of Chinese and Canadian adolescents
001059 (2013)	Danielle Murray [Canada] ; A. Jon Stoessl [Canada]	Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions
001109 (2012)	Rahman Md Mostafeezur [Japon] ; Hossain Md Zakir [Japon] ; Yoshiaki Yamada [Japon] ; Kensuke Yamamura [Japon] ; Koichi Iwata [Japon] ; Barry J. Sessle [Canada] ; Junichi Kitagawa [Japon]	The effect of minocycline on the masticatory movements following the inferior alveolar nerve transection in freely moving rats
001110 (2012)	Shady Rahayel [Canada] ; Johannes Frasnelli ; Sven Joubert	The effect of Alzheimer's disease and Parkinson's disease on olfaction: a meta-analysis.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "effect" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "effect" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    effect
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022